Files
portfolio/Ralph/refs/ref-investigations-documents.md
T

109 lines
4.5 KiB
Markdown

# Reference: Investigations View (= Projects) + Documents View (= Education)
> Extracted from goal.md — Investigations and Documents sections. Two simpler views that share the expandable-row pattern.
---
## Investigations View (= Projects)
Projects presented as diagnostic investigations — tests that were ordered, performed, and returned results.
### Investigation List
```
+--[ Investigation Results ]----------------------------------------------+
| Test Name | Requested | Status | Result |
|------------------------------+-----------+----------+-------------------|
| PharMetrics Interactive | 2024 | Complete | Live (green) |
| Platform | | | |
| Patient Switching Algorithm | 2025 | Complete | 14,000 pts found |
| Blueteq Generator | 2023 | Complete | 70% reduction |
| CD Monitoring System | 2024 | Complete | Population-scale |
| Sankey Chart Analysis Tool | 2023 | Complete | Pathway audit |
| Patient Pathway Analysis | 2024 | Ongoing | In development |
+-------------------------------------------------------------------------+
```
### Status Badges
Styled like laboratory result status indicators:
- **Complete** (green dot): Investigation finished, results available
- **Ongoing** (amber dot): Investigation still in progress
- **Live** (pulsing green dot): Results are actively being used (for PharMetrics, which is a live URL)
### Expanded Investigation View
Clicking an investigation row reveals a detailed "results panel" below the row:
```
PharMetrics Interactive Platform
|-- Date Requested: 2024
|-- Date Reported: 2024
|-- Status: Complete - Live at medicines.charlwood.xyz
|-- Requesting Clinician: A. Charlwood
|-- Methodology:
| Real-time medicines expenditure dashboard providing
| actionable analytics for NHS decision-makers. Built with
| Power BI and SQL, tracking expenditure across the 220M
| prescribing budget.
|-- Results:
| - Real-time tracking of medicines expenditure
| - Actionable analytics for budget holders
| - Self-serve model for wider team
|-- Tech Stack: Power BI, SQL, DAX
|-- [View Results ->] (external link to medicines.charlwood.xyz)
```
The expanded view uses a tree-like indented structure (with box-drawing characters in monospace) to present the investigation report. This mirrors how lab results and imaging reports appear in clinical systems — structured, indented, with labelled fields.
### "View Results" Link
For PharMetrics (the only project with a live URL), a "View Results" button appears styled as an NHS blue action button. For internal projects, this button is absent.
---
## Documents View (= Education & Certifications)
Education and certifications presented as attached documents in the patient record.
### Document List
```
+--[ Attached Documents ]-------------------------------------------------+
| Type | Document | Date | Source |
|----------------+----------------------------------+---------+------------|
| Certificate | MPharm (Hons) 2:1 | 2015 | UEA |
| Registration | GPhC Pharmacist Registration | 2016 | GPhC |
| Certificate | Mary Seacole Programme (78%) | 2018 | NHS LA |
| Results | A-Levels: Maths A*, Chem B, | 2011 | Highworth |
| | Politics C | | Grammar |
| Research | Drug Delivery & Cocrystals | 2015 | UEA |
| | (75.1% Distinction) | | |
+-------------------------------------------------------------------------+
```
### Document Type Icons
Small document icons from Lucide:
- `FileText` for certificates
- `Award` for registrations
- `GraduationCap` for academic results
- `FlaskConical` for research
### Expanded Document Preview
```
MPharm (Hons) 2:1 - University of East Anglia
|-- Type: Academic Qualification
|-- Date Awarded: 2015
|-- Institution: University of East Anglia, Norwich
|-- Classification: Upper Second-Class Honours (2:1)
|-- Duration: 2011 - 2015 (4 years)
|-- Research: Drug delivery and cocrystals
| Grade: 75.1% (Distinction)
|-- Notes: MPharm is a 4-year integrated Master's degree
required for pharmacist registration in the UK.
```
The preview panel uses the same tree-indented structure as the Investigations expanded view, maintaining visual consistency across the PMR interface.